Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Minerva Biotechnology and Biomolecular Research is Scopus-indexed (Q4, CiteScore 1.3), WoS SCIE. Published by Edizioni Minerva Medica.
Checked against the index lists dated .
ISSN 2724-542XVerify ISSN ↗2724-5934Verify ISSN ↗
Publisher: Edizioni Minerva Medica
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 259 / 325 | 20th | Q4 |
| Applied Microbiology and Biotechnology | 111 / 134 | 17th | Q4 |
| Bioengineering | 148 / 168 | 12th | Q4 |
| Molecular Biology | 370 / 414 | 10th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q4, CiteScore 1.3.
Minerva Biotechnology and Biomolecular Research is Q4 in Biotechnology (rank 259 of 325), Q4 in Applied Microbiology and Biotechnology (rank 111 of 134) and Q4 in Bioengineering (rank 148 of 168), by CiteScore 2025. It is ranked in 4 subject areas in all.
Minerva Biotechnology and Biomolecular Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q4 at the 20th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.163, quartile Q4, with an H-index of 22.
Minerva Biotechnology and Biomolecular Research is published by Edizioni Minerva Medica. Its print ISSN is 2724-542X and its online ISSN is 2724-5934.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Minerva Biotechnology and Biomolecular Research has an h-index of 10 and a 2-year mean of 0.61 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q4. On 2-year citations it ranks #247 of 309 Scopus journals in Biotechnology.
Minerva Biotechnology and Biomolecular Research published 19 papers in 2025; its busiest recent year was 2024 with 35. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2022–2026), authors are most often from Italy (23%), China (12.6%) and India (11.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.